Tuesday - June 3, 2025
Johnson & Johnson Showcases Latest Advancements in Cancer Innovation With More Than 70 Clinical and Real-World Studies at ASCO and EHA
May 27, 2025
RARITAN, New Jersey, May 27 -- Johnson and Johnson Innovative Medicine (formerly the Janssen Pharmaceutical Companies of Johnson and Johnson) issued the following news release:

* * *

Johnson & Johnson showcases latest advancements in cancer innovation with more than 70 clinical and real-world studies at ASCO and EHA

New CARVYKTI data help shift the treatment paradigm in relapsed or refractory multiple myeloma with five-year progression-free survival rat . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products